Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D001249:Asthma / Q000188:drug therapy; D001919:Bradycardia / Q000139:chemically induced; D002302:Cardiac Output / Q000187:drug effects; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D010869:Pindolol / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D013375:Substance Withdrawal Syndrome
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D010869:Pindolol